Triple negative breast cancer (TNBC), defined by the lack of expression of the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2), comprises approximately 15% of all BC and is associated with the worst prognosis of all subtypes. Here, ESR1 is linked to triple-negative breast carcinoma.